HomeStartups & VentureArticle
Startups · Biztoc.com

Sightera Biosciences closes €3M pre-seed to expand its patient-derived AI drug discovery platform

By tech.euJuly 17, 2026 · 1 min read

Sightera Biosciences, a Belgian techbio company using generative AI to develop novel small-molecule therapies, has raised €3 million in a pre-seed funding round led by Entourage, Anacura and QBIC. A spin-off from the University of Antwerp and Antwerp Universi…

Sightera Biosciences, a Belgiantechbio company using generative AI to develop novel small-molecule therapies,has raised 3 million in a pre-seed funding round led by Entourage, Anacura andQBIC.A spin-…

Startups & Venture
Startups · Biztoc.com
The Sovereign Post
■ More from Startups & Venture